Navigating the regulatory road to approval for cancer gene therapies

Cancer Gene Ther. 2015 Dec;22(12):553. doi: 10.1038/cgt.2015.62.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Genetic Therapy / legislation & jurisprudence*
  • Humans
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Oncolytic Virotherapy*
  • United States
  • United States Food and Drug Administration